SIRT3 and neoplasm: The research group led by Liu Guangwei from the School of Life Sciences at Beijing Normal University has found that the NAD+- dependent deacetylase SIRT3 in mitochondria can regulate the differentiation and function of TFH cells, and play a key regulatory role in anti-tumor immunity.